Cargando…
Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery
Glycosylation is estimated to be found in over 50% of human proteins. Aberrant protein glycosylation and alteration of glycans are closely related to many diseases. More than half of the cancer biomarkers are glycosylated-proteins, and specific glycoforms of glycosylated-proteins may serve as biomar...
Autores principales: | Zhang, Ying, Jiao, Jing, Yang, Pengyuan, Lu, Haojie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017703/ https://www.ncbi.nlm.nih.gov/pubmed/24872809 http://dx.doi.org/10.1186/1559-0275-11-18 |
Ejemplares similares
-
Mass Spectrometry-Based Glycoproteomic Workflows for Cancer Biomarker Discovery
por: Doud, Emma H., et al.
Publicado: (2023) -
Mass Spectrometry-Based Glycoproteomics and Prostate Cancer
por: Gabriele, Caterina, et al.
Publicado: (2021) -
Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review
por: Zhong, Li, et al.
Publicado: (2021) -
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
por: Riley, Nicholas M., et al.
Publicado: (2020) -
Glycoproteomics-Based Identification of Cancer Biomarkers
por: Kim, Evelyn H., et al.
Publicado: (2011)